(19)
(11) EP 1 957 115 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
05.03.2014 Bulletin 2014/10

(45) Mention of the grant of the patent:
15.01.2014 Bulletin 2014/03

(21) Application number: 06827784.7

(22) Date of filing: 13.11.2006
(51) International Patent Classification (IPC): 
A61K 39/395(2006.01)
 A61P 35/00(2006.01)
(86) International application number:
PCT/US2006/044090
(87) International publication number:
WO 2007/059082 (24.05.2007 Gazette 2007/21)

(54)

METHOD OF TREATING OVARIAN AND RENAL CANCER USING ANTIBODIES AGAINST T CELL IMMUNOGLOBULIN DOMAIN AND MUCIN DOMAIN 1 (TIM-1) ANTIGEN

VERFAHREN ZUR BEHANDLUNG VON OVARIAL- UND NIERENKARZINOM MIT ANTIKÖRPERN GEGEN T-ZELL-IMMUNGLOBULIN-DOMÄNEN- UND MUCIN-DOMÄNEN-1-(TIM-1)-ANTIGEN

METHODE DE TRAITEMENT DU CANCER DE L'OVAIRE ET DU REIN UTILISANT DES ANTICORPS DIRIGES CONTRE L'ANTIGENE A DOMAINE 1 DE MUCINE ET A DOMAINE IMMUNOGLOBULINE DES LYMPHOCYTES T (TIM-1)

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 10.11.2005 US 735574 P

(43) Date of publication of application:
20.08.2008 Bulletin 2008/34

(60) Divisional application:
12174847.9 / 2548583

(73) Proprietor: Celldex Therapeutics, Inc.
Needham, MA 02494 (US)

(72) Inventors:
  • TSE, Kam, Fai
    Clinton, CT 06413 (US)
  • POLLACK, Vincent, A.
    Gales Ferry, CT 06335 (US)
  • MACDOUGALL, John
    Hamden, CT 06517 (US)
  • SHENOY, Suresh, G.
    Branford, CT 06405 (US)
  • MANSFIELD, Traci
    Guilford, CT 06437 (US)
  • LICHENSTEIN, Henri
    Guilford, CT 06437 (US)
  • JEFFERS, Michael, E.
    Branford, CT 06405 (US)
  • LAROCHELLE, William, J.
    Madison, CT 06443 (US)

(74) Representative: Mintz Levin Cohn Ferris Glovsky and Popeo LLP 
Alder Castle 10 Noble Street
London EC2V 7JX
London EC2V 7JX (GB)


(56) References cited: : 
WO-A2-2004/084823
   
     
    Remarks:
    The file contains technical information submitted after the application was filed and not included in this specification
     
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).